Cytokine storms caused by novel coronavirus 2019 and treatment for cardiac injury.
Eur Rev Med Pharmacol Sci
; 24(23): 12527-12535, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: covidwho-995013
ABSTRACT
Since December 2019, an outbreak of a new coronavirus, COVID-19, infection has been taking place. At present, COVID-19 has spread to most countries worldwide. The latest evidence suggests that cytokine storm syndrome (CSS) is an important cause of the transition from mild to critical pneumonia and critically ill patients' death. The sudden exacerbation of COVID-19 may be related to a cytokine storm. Therefore, early identification and active treatment of CSS may play very important roles in improving the patients' prognosis, and these tasks are given attention in the current treatment of new Coronavirus pneumonia. However, there is still no specific medicine for this purpose. This article reviews cytokine storms and conducts an exploratory review of pharmacotherapy for cytokine storms to provide a reference for clinical treatment.
Texto completo:
Disponible
Colección:
Bases de datos internacionales
Base de datos:
MEDLINE
Asunto principal:
Síndrome de Liberación de Citoquinas
/
COVID-19
/
Miocarditis
Tipo de estudio:
Estudio pronóstico
Límite:
Humanos
Idioma:
Inglés
Revista:
Eur Rev Med Pharmacol Sci
Asunto de la revista:
Farmacología
/
Toxicología
Año:
2020
Tipo del documento:
Artículo
País de afiliación:
Eurrev_202012_24050
Similares
MEDLINE
...
LILACS
LIS